DZ2714A1 - Traitement du mal fonctionnement sexuel féminin. - Google Patents

Traitement du mal fonctionnement sexuel féminin.

Info

Publication number
DZ2714A1
DZ2714A1 DZ990015A DZ990015A DZ2714A1 DZ 2714 A1 DZ2714 A1 DZ 2714A1 DZ 990015 A DZ990015 A DZ 990015A DZ 990015 A DZ990015 A DZ 990015A DZ 2714 A1 DZ2714 A1 DZ 2714A1
Authority
DZ
Algeria
Prior art keywords
treatment
sexual dysfunction
female sexual
female
dysfunction
Prior art date
Application number
DZ990015A
Other languages
English (en)
Inventor
Regab El-Rashidy
Bruce Ronsen
Original Assignee
Pentech Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pentech Pharmaceuticals Inc filed Critical Pentech Pharmaceuticals Inc
Application granted granted Critical
Publication of DZ2714A1 publication Critical patent/DZ2714A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DZ990015A 1998-01-30 1999-01-30 Traitement du mal fonctionnement sexuel féminin. DZ2714A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/016,252 US5945117A (en) 1998-01-30 1998-01-30 Treatment of female sexual dysfunction

Publications (1)

Publication Number Publication Date
DZ2714A1 true DZ2714A1 (fr) 2003-09-01

Family

ID=21776169

Family Applications (1)

Application Number Title Priority Date Filing Date
DZ990015A DZ2714A1 (fr) 1998-01-30 1999-01-30 Traitement du mal fonctionnement sexuel féminin.

Country Status (34)

Country Link
US (2) US5945117A (fr)
EP (1) EP1056419A4 (fr)
JP (1) JP2002501875A (fr)
KR (1) KR20010040477A (fr)
CN (1) CN1250221C (fr)
AR (1) AR017976A1 (fr)
AU (1) AU752928B2 (fr)
BG (1) BG64667B1 (fr)
BR (1) BR9908038A (fr)
CA (1) CA2322289A1 (fr)
CO (1) CO4970819A1 (fr)
CR (1) CR5959A (fr)
DZ (1) DZ2714A1 (fr)
GC (1) GC0000096A (fr)
GT (1) GT199900013A (fr)
HK (1) HK1040901B (fr)
HN (1) HN1999000015A (fr)
HU (1) HUP0101268A3 (fr)
IL (2) IL137569A0 (fr)
JO (1) JO2085B1 (fr)
MA (1) MA26600A1 (fr)
MX (1) MXPA00007447A (fr)
NO (1) NO319821B1 (fr)
NZ (1) NZ506597A (fr)
PA (1) PA8467801A1 (fr)
PE (1) PE20000240A1 (fr)
PL (1) PL194350B1 (fr)
SK (1) SK11362000A3 (fr)
TN (1) TNSN99008A1 (fr)
TR (1) TR200002220T2 (fr)
TW (1) TW550069B (fr)
UY (1) UY25374A1 (fr)
WO (1) WO1999038467A1 (fr)
ZA (1) ZA99686B (fr)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020165122A1 (en) * 1994-04-22 2002-11-07 Heaton Jeremy P. W. Method and compositions for the treatment or amelioration of female sexual dysfunction
US6395744B1 (en) * 1994-04-22 2002-05-28 Queen's University At Kingston Method and compositions for the treatment or amelioration of female sexual dysfunction
US20050065161A1 (en) * 1996-02-02 2005-03-24 Nitromed, Inc. Nitrosated and nitrosylated alpha-adrenergic receptor antagonist compounds, compositions and their uses
US6472425B1 (en) 1997-10-31 2002-10-29 Nitromed, Inc. Methods for treating female sexual dysfunctions
US5945117A (en) * 1998-01-30 1999-08-31 Pentech Pharmaceuticals, Inc. Treatment of female sexual dysfunction
AU2003204720B2 (en) * 1998-05-29 2006-06-29 Tap Pharmaceutical Products Inc. Methods for the normalization of sexual response and amelioration of long term genital tissue degradation
EP1089736A2 (fr) * 1998-06-22 2001-04-11 Queen's University At Kingston Procede et compositions pour le traitement ou l'amelioration des dysfonctionnements sexuels de la femme
US20050245494A1 (en) * 1999-07-01 2005-11-03 40 J's Llc Methods to treat one or all of the defined etiologies of female sexual dysfunction
US20050020547A1 (en) * 1999-11-08 2005-01-27 Pfizer Inc. Compounds for the treatment of female sexual dysfunction
BR0005797A (pt) * 2000-03-20 2001-10-16 Abbott Lab Métodos para o tratamento de disfunção sexual com apomorfina em nìveis de concentração plasmática especificados
KR20030036157A (ko) * 2000-04-07 2003-05-09 탭 파마슈티칼 프로덕츠 인코포레이티드 아포모르핀 유도체 및 이의 사용 방법
AU6124401A (en) * 2000-05-09 2001-11-20 Nitromed Inc Infrared thermography and methods of use
ATE369868T1 (de) * 2000-06-27 2007-09-15 Qualilife Pharmaceuticals Inc Zusammensetzungen und verfahren zur behandlung der weiblichen sexuellen reaktion
US7223406B2 (en) * 2000-07-21 2007-05-29 The Regents Of The University Of California Methods and compositions for preventing and treating male erectile dysfunction and female sexual arousal disorder
US6852323B2 (en) 2000-07-21 2005-02-08 The Regents Of The University Of California Methods and compositions for preventing and treating male erectile dysfunction and female sexual arousal disorder
US20020065286A1 (en) * 2000-08-21 2002-05-30 Davies Michael John Treatment of wounds
IL155667A0 (en) 2000-11-15 2003-11-23 Tap Pharmaceutical Prod Inc Treatment of anti-depression drug-induced sexual dysfunction with apomorphine
AU2689502A (en) * 2000-11-22 2002-06-03 Abbott Lab The use of selective dopamine d4 receptor agonists for treating sexual dysfunction
CA2435546A1 (fr) * 2001-02-08 2002-08-15 Alice C. Martino Medicament a action rapide pour le traitement de dysfonctionnements sexuels
JP2005526790A (ja) * 2002-03-19 2005-09-08 ミシェル ホリック アポモルフィンおよび類縁体の配糖体およびオルトエステル配糖体誘導体、ならびにそれらの使用方法
US20030219696A1 (en) * 2002-05-23 2003-11-27 Moreland Gerald W. Method and apparatus for preventing backflow in dental saliva evacuators
GB0219961D0 (en) 2002-08-28 2002-10-02 Pfizer Ltd Oxytocin inhibitors
GB0221711D0 (en) * 2002-09-19 2002-10-30 Ardana Bioscience Ltd Methods
US20040138291A1 (en) * 2002-10-10 2004-07-15 Adams Michael A. Treatment of sexual dysfunction
CA2451267A1 (fr) * 2002-12-13 2004-06-13 Warner-Lambert Company Llc Utilisations pharmaceutiques de ligands alpha2delta
US20040204439A1 (en) * 2003-04-14 2004-10-14 Staniforth John Nicholas Composition, device, and method for treating sexual dysfunction via inhalation
US20060178394A1 (en) * 2003-04-14 2006-08-10 Staniforth John N Pharmaceutical compositions comprising apomorphine for pulmonary inhalation
US7276246B2 (en) * 2003-05-09 2007-10-02 Cephalon, Inc. Dissolvable backing layer for use with a transmucosal delivery device
US7306812B2 (en) 2003-05-09 2007-12-11 Cephalon, Inc. Dissolvable backing layer for use with a transmucosal delivery device
GB0314054D0 (en) * 2003-06-17 2003-07-23 Pfizer Ltd Amide derivatives as selective serotonin re-uptake inhibitors
US20050054688A1 (en) * 2003-08-08 2005-03-10 Pfizer Inc Selective serotonin reuptake inhibitors in the treatment of disease
DE10338174A1 (de) * 2003-08-20 2005-03-24 Lts Lohmann Therapie-Systeme Ag Transdermale Arzneimittelzubereitungen mit Wirkstoffkombinationen zur Behandlung der Parkinson-Krankheit
US7291640B2 (en) * 2003-09-22 2007-11-06 Pfizer Inc. Substituted triazole derivatives as oxytocin antagonists
GB0409744D0 (en) * 2004-04-30 2004-06-09 Pfizer Ltd Novel compounds
AP2006003771A0 (en) * 2004-04-30 2006-10-31 Warner Lambert Co Substituted morpholine compounds for the treatmentof central nervous system disorders
WO2006100588A1 (fr) * 2005-03-21 2006-09-28 Pfizer Limited Derives de triazole substitues utilises en tant qu'antagonistes d'oxytocine
JP2008533192A (ja) * 2005-03-21 2008-08-21 ファイザー・リミテッド オキシトシンアンタゴニストとしての置換されたトリアゾール誘導体
WO2006105615A1 (fr) * 2005-04-08 2006-10-12 Ozpharma Pty Ltd Procede d’administration orale
WO2007017752A1 (fr) * 2005-08-10 2007-02-15 Pfizer Limited Derives de triazole substitues en tant qu'antagonistes d'oxytocine
WO2007110868A2 (fr) 2006-03-28 2007-10-04 Atir Holding S.A. Composés hétérocycliques et leurs utilisations dans le traitement de troubles sexuels
US7800094B2 (en) * 2007-06-11 2010-09-21 Macronix International Co., Ltd. Resistance memory with tungsten compound and manufacturing
PT2952191T (pt) 2009-06-12 2018-11-30 Sunovion Pharmaceuticals Inc Apomorfina sublingual
US20130210867A1 (en) * 2010-04-15 2013-08-15 Life Science Enhancement Corporation Methods and compositions for enhancing female sexual arousal and treating female sexual dysfunction
EP2651357B1 (fr) 2010-12-16 2020-04-01 Sunovion Pharmaceuticals Inc. Films sublinguaux
WO2012140642A1 (fr) 2011-04-10 2012-10-18 Atir Holding S.A. Composés hétérocycliques et leurs utilisations dans le traitement de troubles sexuels
EP2545905A1 (fr) 2011-07-11 2013-01-16 Britannia Pharmaceuticals Limited Nouvelle composition thérapeutique contenant de l'apomorphine en tant que principe actif
CA3127926A1 (fr) 2015-04-21 2016-10-27 Sunovion Pharmaceuticals Inc. Methodes de traitement de la maladie de parkinson par l'administration d'apomorphine a une muqueuse orale

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4521421A (en) * 1983-09-26 1985-06-04 Eli Lilly And Company Treatment of sexual dysfunction
JPH07506823A (ja) * 1992-05-18 1995-07-27 スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー 記憶障害，性的機能不全およびパーキンソン氏病の治療のためのインドロン誘導体の使用
US5565466A (en) * 1993-08-13 1996-10-15 Zonagen, Inc. Methods for modulating the human sexual response
ATE312609T1 (de) * 1994-04-22 2005-12-15 Pentech Pharmaceuticals Inc Sublinguale zusammensetzung enthaltend apomorphine zur diagnose der funktionellen impotenz
US5562917A (en) * 1994-12-23 1996-10-08 Pentech Pharmaceuticals, Inc. Transdermal administration of apomorphine
US5624677A (en) * 1995-06-13 1997-04-29 Pentech Pharmaceuticals, Inc. Controlled release of drugs delivered by sublingual or buccal administration
US5945117A (en) * 1998-01-30 1999-08-31 Pentech Pharmaceuticals, Inc. Treatment of female sexual dysfunction

Also Published As

Publication number Publication date
PL342062A1 (en) 2001-05-21
HN1999000015A (es) 1999-08-23
GT199900013A (es) 2001-07-20
AR017976A1 (es) 2001-10-24
HUP0101268A2 (hu) 2001-09-28
IL137569A0 (en) 2001-07-24
PL194350B1 (pl) 2007-05-31
ZA99686B (en) 1999-07-28
AU752928B2 (en) 2002-10-03
SK11362000A3 (sk) 2001-02-12
BR9908038A (pt) 2002-01-02
MXPA00007447A (es) 2006-01-25
MA26600A1 (fr) 2004-12-20
NZ506597A (en) 2003-07-25
NO20003845L (no) 2000-09-28
JP2002501875A (ja) 2002-01-22
HUP0101268A3 (en) 2002-12-28
GC0000096A (en) 2005-06-29
WO1999038467A1 (fr) 1999-08-05
PA8467801A1 (es) 2000-09-29
NO20003845D0 (no) 2000-07-27
IL137569A (en) 2006-08-01
CA2322289A1 (fr) 1999-08-05
EP1056419A1 (fr) 2000-12-06
HK1040901A1 (en) 2002-06-28
BG64667B1 (bg) 2005-11-30
NO319821B1 (no) 2005-09-19
TW550069B (en) 2003-09-01
CN1313742A (zh) 2001-09-19
EP1056419A4 (fr) 2007-05-02
US5945117A (en) 1999-08-31
TNSN99008A1 (fr) 2005-11-10
US6193992B1 (en) 2001-02-27
TR200002220T2 (tr) 2000-12-21
CO4970819A1 (es) 2000-11-07
UY25374A1 (es) 1999-09-27
JO2085B1 (en) 2000-05-21
KR20010040477A (ko) 2001-05-15
BG104715A (bg) 2001-02-28
CN1250221C (zh) 2006-04-12
AU2564499A (en) 1999-08-16
CR5959A (es) 1999-07-28
PE20000240A1 (es) 2000-03-31
HK1040901B (zh) 2006-11-24

Similar Documents

Publication Publication Date Title
MA26600A1 (fr) Traitement du dysfonctionnement sexuel feminin.
IS2494B (is) Notkun á morfólínóli til meðhöndlunar á kynferðislegri vanvirkni
EP1027057A4 (fr) Traitement du dysfonctionnement sexuel chez la femme
ATE269866T1 (de) Intranasale zubereitungen zur behandlung sexueller störungen
IL153492A0 (en) Treatment of male sexual dysfunction
CH1143977H1 (fr) 2-Oxy-benzoxazine-4-ones destinees au traitement de l'obesite
ID30276A (id) Metode untuk mengobati gangguan-gangguan seksual
FI972205L (fi) cGmp-PDE:n estäjiä erektiohäiriön hoidossa
DE60103770D1 (de) Botulinumtoxin zur behandlung endokriner erkrankungen
PL359726A1 (en) Animal device for collecting an animal's seminal fluid
DE60105614D1 (de) Oxazinochinolone für die behandlung viraler infektionen
MA26835A1 (fr) Traitement de l'emphyseme utilisant des agonistes retinoides selectifs des rar.
NO20024442D0 (no) Behandling av seksuell dysfunksjon med apomorfin
NO20032189L (no) Behandling av antidepresjonsmiddel-indusert seksuell dysfunksjon med apomorfin
NO20030978D0 (no) Behandling av diuresedysfunksjon
DE50009813D1 (de) Kombinationpräparat zur behandlung von sexueller dysfunktion
MA25852A1 (fr) Methode pour le traitement de l'inflammation.
DE60112768D1 (de) Behandlung von entzündlichen erkrankungen
DE60122601D1 (de) Behandlung von entzündlichen Darmerkrankungen
FR2765214B1 (fr) Traitement de granulat par un latex anti-desenrobage
EP1225919A4 (fr) Traitement du cancer
EA200200927A1 (ru) Способ профилактики и лечения заболеваний иммунной системы и средство для его осуществления
FI916133A7 (fi) Terapeuttinen laite miehen häiriöllistä seksuaalista toimintaa varten
GB0011926D0 (en) Treatment of sexual dysfunction
KR960030459U (ko) 성기능 강화 링